PRT2527, a Novel Highly Selective Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, Has Potent Anti-Leukemic Activity in Preclinical Primary Models of Human B-ALL, T-ALL, and CLL
العنوان: | PRT2527, a Novel Highly Selective Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, Has Potent Anti-Leukemic Activity in Preclinical Primary Models of Human B-ALL, T-ALL, and CLL |
---|---|
المؤلفون: | Neha Bhagwat, Bruce Ruggeri, Yang Zhang, Yaron Mosesson, Clare Killick-Cole, Veena Jagannathan, Peggy Scherle |
المصدر: | Blood. 140:505-506 |
بيانات النشر: | American Society of Hematology, 2022. |
سنة النشر: | 2022 |
مصطلحات موضوعية: | Immunology, Cell Biology, Hematology, Biochemistry |
تدمد: | 1528-0020 0006-4971 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::f35a1710f6890a66e759ae3e105d34e6 https://doi.org/10.1182/blood-2022-158998 |
رقم الأكسشن: | edsair.doi...........f35a1710f6890a66e759ae3e105d34e6 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 15280020 00064971 |
---|